Last reviewed · How we verify

NCT05493696

Antigravity Treadmill Training on Gait Characteristics and Balance

Completed NA Last updated 9 August 2022
What this trial tests

NA trial testing Antigravity treadmill in Burns in 55 participants. Completed in 28 July 2022.

Timeline
15 June 2022
Primary endpoint
15 July 2022
28 July 2022

Quick facts

Lead sponsorUmm Al-Qura University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment55
Start date15 June 2022
Primary completion15 July 2022
Estimated completion28 July 2022
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Umm Al-Qura University

Who can join

Adults 18 to 35, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Severe burn injuries are associated with hypermetabolic responses and increased catabolism. These generalized changes lead to a vast loss of muscle mass and cause reduced muscle strength and endurance, limited walking ability, and reduced functional mobility Recently, the antigravity treadmill or lower body positive pressure (LBPP) technology has been developed as a unique system of maintaining a participant's body weight all through treadmill training and developing low-load treadmill walking using a unique treadmill system that allows gaining the benefits of low-load treadmill walking without interrupting with locomotion dynamics

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Burns

Currently open trials in the same condition.

Other Umm Al-Qura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing